Amgen and India’s Jubilant In Drug Discovery Partnership
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Jubilant Biosys, a subsidiary of Indian contract research and manufacturing services provider Jubilant Organosys, has entered into a drug discovery partnership with Amgen to develop a portfolio of new drugs across various therapeutic areas